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The molecular environment of the host can have profound effects
on the behavior of resident bacterial species. We recently estab-
lished how the sensing and response of enterohemorrhagic Escher-
ichia coli (EHEC) to D-serine (D-Ser) resulted in down-regulation of
type 3 secretion system-dependent colonization, thereby avoiding
unfavorable environments abundant in this toxic metabolite. How-
ever, this model ignores a key determinant of the success of bacte-
rial pathogens, adaptive evolution. In this study, we have explored
the adaptation of EHEC to D-Ser and its consequences for patho-
genesis. We rapidly isolated multiple, independent, EHEC mutants
whose growth was no longer compromised in the presence of
D-Ser. Through a combination of whole-genome sequencing and
transcriptomics, we showed that tolerance could be attributed to
disruption of one of two D-Ser transporters and/or activation of a
previously nonfunctional D-Ser deaminase. While the implication of
cytoplasmic transport in D-Ser toxicity was unsurprising, disruption
of a single transporter, CycA, was sufficient to completely overcome
the repression of type 3 secretion system activity normally associ-
ated with exposure to D-Ser. Despite the fact that this reveals a
mechanism by which evolution could drive a pathogen to colonize
new niches, interrogation of sequenced E. coli O157:H7 genomes
showed a high level of CycA conservation, highlighting a strong
selective pressure for functionality. Collectively, these data show
that CycA is a critically important conduit for D-Ser uptake that is
central to the niche restriction of EHEC.
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Pathogenic bacteria sense and respond to a plethora of signalsas they traverse through the host. The integration of these
signals into appropriate changes in behavior is an important
determinant of a pathogen’s success. The intestine is a particularly
complex and dynamic environment, containing signals from the
host, the microbiome, and large molecular perturbations from diet.
Competition within this environment extends beyond simply con-
testing for food, as metabolites can influence gene expression and
even evolutionary adaptation of the bacteria within the gut.
Free D-amino acids represent an often-overlooked aspect of the
human diet. Dietary consumption of D-amino acids has been es-
timated at 100 mg/d (1). These compounds, unlike their L-enan-
tiomers, require specialized catabolic pathways in order to be used
as energy sources (2–7), and as such represent an important part
of nutritional competition and metabolic signaling to enteric
species. The peptidoglycan sacculus of gram-negative bacteria is
strengthened by cross-links containing D-alanine and D-glutamate
(8). It has been demonstrated that some bacteria possess the
ability to produce a large number of additional D-amino acids by
virtue of a broad-spectrum racemase and these compounds play a
role in regulating stationary-phase cell-wall structure (9). The
levels of D-amino acids vary at different sites within the host, with
D-serine (D-Ser), for example, being found at ∼1 μM in the gut (10)
and ∼1 mM in the urine (11), where it is the most abundant D-amino
acid (12). D-Ser is also found at localized high concentrations in
certain brain tissues, where it functions as a neurotransmitter by
binding to N-methyl D-aspartate receptors (13).
Extraintestinal pathogenic Escherichia coli (ExPEC), a group
that is primarily composed of uropathogenic E. coli (UPEC) and
neonatal meningitis-associated E. coli (NMEC), exhibit the ability
to disseminate from the intestine and establish infection at extra-
intestinal sites (14). Conversely, the attaching/effacing (A/E) path-
ogens, so-called due to their formation of pedestal-like lesions on
the surface of infected cells, are normally restricted to the intestine
(15). Colonization by this group, which includes enterohemorrhagic
E. coli (EHEC), is dependent upon the locus of enterocyte ef-
facement (LEE)-encoded type 3 secretion system (16). Catabolism
of D-Ser in E. coli is facilitated by the dsdCXA locus that comprises a
transcriptional activator, inner-membrane transporter, and deami-
nase/dehydratase (3). While up to 85% of pyelonephritis and uro-
sepsis isolates have been found to possess an intact dsdCXA locus
(11), only 5.7% of isolates possessing the LEE-encoded type 3
secretion system carried an intact locus (10). In the case of the
prototype EHEC isolate EDL933, a sucrose utilization operon
encoded by cscBKAR has been acquired by recombination, resulting
in the loss of the transcriptional activator-encoding gene dsdC and
an inactivating truncation of the transporter-encoding gene dsdX
(17). Without DsdC the system is nonfunctional, resulting in D-Ser
toxicity. The extremely rare concurrent carriage of the LEE and
dsd systems indicates a strong pressure for A/E pathogens to avoid
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environments with high levels of D-Ser. A number of inner-
membrane transporters have been implicated in specific uptake of
D-Ser, including DsdX (18), which is encoded in the dsdCXA locus,
CycA (19), and SstT (20).
We recently described how EHEC can sense D-Ser (21) and
respond by reducing expression of its primary colonization appa-
ratus, the LEE-encoded type 3 secretion system (10). This allows
for restriction of EHEC to a more favorable niche within the gut
where D-Ser concentrations are low (10), compared with envi-
ronments such as the bladder, where D-Ser levels are higher (11).
In addition to virulence repression by D-Ser, an SOS-like response
is activated, leading to a higher rate of genomic variability (22),
likely reflecting the bacterium attempting to overcome the stress
induced by D-Ser exposure. Together with the observation that
LEE-positive enteric E. coli have evolved to lose the ability to
catabolize D-Ser (10), these findings corroborate the role of D-Ser
in niche restriction of LEE-positive E. coli.
Here we expand on these studies by investigating if EHEC can
adapt to overcome this evolutionary bottleneck. We describe the
genetic and phenotypic consequences of repeated in vitro expo-
sure of EHEC to D-Ser. Tolerance to D-Ser convergently evolved
by distinct mechanisms and resulted in an ability to overcome not
only the growth-inhibitory effects of D-Ser but also the majority of
transcriptional alterations associated with D-Ser, including type 3
secretion system-dependent colonization. We discuss these mecha-
nistic insights and the implications that they have for the pathogenic
lifestyle of EHEC.
Results
D-Ser Exposure Can Induce the Evolution of Tolerant EHEC Isolates. The
prototype UPEC and NMEC strains CFT073 and CE10 were
chosen for inclusion in this study as, like 85% of UPEC (11) and
97.5% of NMEC (23), they possess complete, responsive, and
functional dsd loci (Fig. 1A). The NMEC CE10 isolate is inter-
esting as it carries two copies of the locus. EHEC TUV93-0
(a Shiga toxin-negative derivative of EDL933), on the other hand, is
typical of the majority of diarrheagenic LEE-pathogenicity island-
carrying E. coli in that it possesses a genomic rearrangement up-
stream of dsdA leading to loss of dsdCX and hence loss of function
(10, 23). EHEC cannot grow on D-Ser as a sole carbon source, and
its growth in glucose-containing minimal medium is strongly
inhibited by D-Ser (Fig. 1 B and C). The specific growth rate (SGR)
for EHEC was found to decrease from 0.63 h−1, in agreement with
previous reports for M9 + glucose (24), to 0.19 h−1 (P = 0.003)
upon inclusion of D-Ser, whereas no significant decrease was ob-
served with UPEC or NMEC (SI Appendix, Fig. S1). This indicated
that D-Ser exerted a sublethal growth-inhibitory effect on EHEC
and alluded to the possibility that tolerant mutants could arise by
repeated exposure as the bacteria attempt to overcome the inhibi-
tion of growth. To test this, we repeatedly batch-cultured EHEC in
the presence of D-Ser for a period of 10 d as outlined in Fig. 2A.
When subculturing on each day, a sample was serially diluted and
spot-plated on solid M9 medium containing glucose and D-Ser
(i.e., the same selective conditions as the flask culture). Importantly,
this allowed for discrimination of putatively tolerant clones by virtue
of their ability to form large colonies. The resulting clones were
termed large-colony variants (LCVs) and numbers were assigned
from the passage number at which they were isolated (for example,
LCV3 was isolated from the third 24-h batch culture). LCV1A and
2A were isolated from a repeat experiment with two successive
batch cultures, while LCV10B represented a second colony selected
for analysis from the 10-d culture.
In order to validate the selection process, pure cultures of each
isolate were tested for growth rate in D-Ser–containing medium.
Two early clones (LCV1 and LCV3) appeared to be false posi-
tives as no tolerance to D-Ser was observed (Fig. 2B and SI
Appendix, Fig. S2). Six clones (LCV4 to 7, 1A, and 2A) displayed
intermediate levels of tolerance (SGR significantly higher than
wild-type [WT] D-Ser but lower than WT, 0.31 to 0.38 h−1;
Fig. 2C and SI Appendix, Fig. S2). The remaining five clones
(LCV2, 8 to 10, and 10B) displayed complete tolerance to D-Ser
with growth rates similar to that of WT EHEC cultured in the
absence of D-Ser (Fig. 2C and SI Appendix, Fig. S2). As such,
D-Ser–tolerant mutants can be isolated and positively selected
for by repeated culture in the presence of toxic D-Ser. Strikingly,
the observation of two distinct levels of tolerance alluded to at
least two independent mechanisms of tolerance.
The Evolution of Tolerance Alters the Transcriptional Response to
D-Ser. Before characterizing the molecular basis of D-Ser toler-
ance, it was crucial to establish whether this tolerance phenotype
had any implications for the distinct transcriptional responses
that we have previously associated with exposure of EHEC to
D-Ser, namely repression of type 3 secretion-mediated coloni-
zation (10) and activation of an SOS-like response via RecA
induction (10, 22). We used transcriptional reporters of the LEE
master regulator (Fig. 3A) and recA (Fig. 3B). As LCV1 and
LCV3 did not exhibit tolerance, one would expect them to be-
have as the WT with respect to both LEE1 repression and recA
induction. This was indeed the case, further supporting the no-
tion that these are false-positive isolates for D-Ser tolerance. The
majority of D-Ser–tolerant isolates showed no repression of
LEE1 in response to D-Ser (LCV4 to 10) and no significant ac-
tivation of recA transcription. This group consists of both par-
tially tolerant and completely tolerant isolates (Fig. 2 C and D).
Two isolates exhibited recovery from recA activation but main-
tained WT levels of type 3 repression (LCV2 and LCV10B;
Fig. 3 A and B).
Next, a single representative from these three groupings (no
recA induction, complete tolerance: LCV2; no recA induction or
type 3 repression with partial tolerance: LCV7; no recA induc-
tion or type 3 repression with complete tolerance: LCV10) was
tested for infection of host epithelial cells in the presence or
absence of D-Ser (Fig. 3 C–E). Adherent bacteria formed char-
acteristic A/E lesions with regions of pronounced actin conden-
sation being visible adjacent to the majority of bacterial cells
(Fig. 3C). Only WT EHEC showed a significant reduction in
adhesion levels in terms of the numbers of bacteria attached per
cell (Fig. 3D) and the percentage of cells infected (Fig. 3E).
Surprisingly, LCV2 exhibited reduced LEE1 promoter activity in
the presence of D-Ser while displaying higher levels of coloni-
zation (Fig. 3A); however, we will later discuss further a mech-
anism by which LCV2 and LCV10B may gain an advantage in
the presence of D-Ser. Taken together, these findings illustrate
that tolerance starkly affects the transcriptional response to
D-Ser and results in overcoming the inhibitory effects of D-Ser on
colonization, a factor that could have important implications for
niche specificity of such mutants.
The Molecular Basis of D-Ser Tolerance. Having observed variable
levels of tolerance to D-Ser and distinct patterns of recovery from
the transcriptional shift normally associated with D-Ser, we pre-
dicted that three distinct mechanisms of tolerance were at play.
First, the genomes of each isolate were sequenced to 30-fold
coverage and aligned to a resequenced genome of the EHEC
parental strain from this study. Single-nucleotide polymorphisms
(SNPs) were called where present in 90% of reads. Of the
nonsynonymous SNPs present in tolerant isolates, only those in
cycA appeared to be strongly selected for, being present in both
experimental replicates (i.e., LCV4 to 10 [premature stop at
position K280] and LCV1A [I257K]; Table 1), appearing early
(batch cultures 4 and 1, respectively), and being maintained in
the 10-d experiment until the final day of sampling. CycA is a
previously characterized D-Ser/D-cycloserine/D-alanine/glycine/
L-alanine transporter (18, 19). While the cycA mutation alone
could putatively be responsible for the tolerance phenotype of
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the majority of the tolerant mutants (LCV4 to 10 and 1A), two
questions remained: Why were some cycA mutants more tolerant
than others, and what was the mechanism of tolerance for LCV2
and LCV10B that appear to encode WT cycA?
To address the first question, we examined the transcriptome
of a representative from the completely tolerant group that
possessed a mutation in cycA—LCV10—and compared it with
the WT. We hypothesized that a transcriptional alteration in this
strain might explain its enhanced tolerance over the partially
tolerant group (LCV4 to 7 and 1A). Wild-type EHEC was found
to significantly differentially express 369 genes in response to
D-Ser (136 up and 233 down; SI Appendix, Table S1), consistent
Fig. 1. EHEC is unable to tolerate D-Ser due to an insertion that truncates the D-Ser catabolism locus. (A) Schematic depicting the D-Ser catabolism locus in
EHEC, UPEC, and NMEC. (B) Growth curves of EHEC, UPEC, and NMEC in M9 + glucose (Glc) ± 1 mM D-Ser. Error bars indicate SEM from a minimum of three
experiments. (C) Schematic illustrating the contrasting effects of D-Ser on dsd− and dsd+ strains of E. coli. While D-Ser catabolism promotes the growth of
UPEC and NMEC, growth of EHEC is severely restricted by D-Ser. In the case of EHEC, D-Ser is transported into the cytosol by CycA and SstT, where it accu-
mulates and induces an SOS-like response and transcriptional repression of type 3 secretion.
Fig. 2. D-Ser–tolerant EHEC mutants evolve and can be selected for by repeated culture in the presence of D-Ser. (A) Experimental workflow of repeated
batch culture for the enrichment of D-Ser–tolerant mutants. (B–D) Growth curves (M9 + glucose + 1 mM D-Ser) of apparent LCV clones obtained after the
indicated number of repeat cultures in D-Ser–containing medium. Error bars indicate SEM from a minimum of three experiments.
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with our previous reports (10). The majority (247/369) of these
differentially expressed genes (DEGs) were oppositely regulated
when comparing the transcriptome of WTD-Ser and LCV10D-Ser
(SI Appendix, Table S1), highlighting the fact that tolerance can
overcome many of the transcriptional effects exerted by D-Ser. A
further 361 genes (new DEGs; SI Appendix, Table S2) were dif-
ferentially expressed in LCV10D-Ser versus WTD-Ser that were not
associated with the response to D-Ser (i.e., WT versus WTD-Ser),
indicating that the transcriptional alterations in LCV10 extended
beyond simply overcoming the normal effects of D-Ser. The most
significant of these was sstT (also known as yjgU) with 87.68-fold
lower expression (false discovery rate adjusted P = 1.86 × 10−107)
in LCV10 than the WT (Fig. 4A). Reduced transcription of sstT
was confirmed by quantitative real-time PCR (LCV10, −147.74-
fold; Fig. 4B) and was also observed in a second completely tol-
erant isolate (LCV9, −92.15-fold), while two partially tolerant
isolates (LCV5 and LCV7) and one tolerant isolate that lacked a
mutation in cycA (LCV2) showed less than a twofold decrease in
transcription. Decreased expression of sstT was found to be con-
stitutive with no significant difference being observed with or
without D-Ser (Fig. 4C). SstT functions as a sodium/serine and
sodium/threonine symporter (20, 25), and hence transcriptional
knockdown had a strong likelihood of facilitating tolerance syn-
ergistically with disruption of cycA.
Disruption of D-Ser Transport as a Means of Conferring Tolerance.We
hypothesized that the mutations acquired in CycA (K280Stop, I257K)
and the marked reduction in sstT transcription led to lack of
function or expression at a level that would not allow for func-
tionality, thereby facilitating the observed phenotypes in LCV4 to
10 and 1A. To confirm these mechanisms, we constructed isogenic
mutants lacking either CycA, SstT, or both transporters and assayed
for tolerance to D-Ser. Deletion of cycA led to enhanced growth
in the presence of D-Ser (Fig. 5A), with SGR increasing from
0.15 to 0.35 h−1 (SI Appendix, Fig. S3). While deletion of sstT caused
only a modest increase in tolerance (Fig. 5B), the increase in SGR
over WTD-Ser was not significant (P = 0.122; SI Appendix, Fig. S3).
Combined disruption of cycA and sstT resulted in complete toler-
ance to D-Ser (Fig. 5C) with a SGR of 0.61 h−1, statistically equiv-
alent to that of WTD-Ser (SI Appendix, Fig. S3). Therefore, disruption
Fig. 3. Tolerance to D-Ser has variable consequences for D-Ser–associated behaviors including type 3 secretion-dependent colonization. (A) LEE1p activity in
the WT and the indicated mutants after 4 h of culture in MEM-HEPES ± 1 mM D-Ser. (B) PrecA activity in the WT and the indicated mutants after a 3-h culture
in M9 + Glc followed by 2 h ± 1 mM D-Ser. *P < 0.05, **P < 0.01, and ***P < 0.001 by paired two-tailed Student’s t test. (C–E) Colonization of HeLa cells as
determined by counting the numbers of EHEC attached per cell after 2 h 45 m of infection. (C) Deconvoluted wide-field microscopy images illustrating DNA
(blue), filamentous actin (red), and EHEC (green) with bacteria being associated with regions of condensed actin, highlighted by a high-magnification image
(Inset) for the WT. (D) Individual counts of bacteria per HeLa cell. A minimum of 331 cells were counted across three experiments. Black lines indicate the
mean. Kruskal–Wallis with Dunn’s post hoc test yielded ***P < 0.001. (E) Percentage of HeLa infected with at least one EHEC cell obtained from cell counts in
D. Ordinary one-way ANOVA of experimental means yielded ***P < 0.001.
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of cycA alone recapitulates the phenotypes of LCV4 to 7 and 1A,
while secondary disruption of sstT in this genetic background reca-
pitulates the phenotype of LCV8 to 10. Sensitivity to D-Ser was
restored in all three deletion mutants by overexpression of either
transporter on the multicopy plasmid pACYC184 (Fig. 5 D–F).
Interestingly, overexpression of CycA led to a hypersensitive phe-
notype with D-Ser inducing a killing effect, as revealed by negative
SGR values being observed in all three mutant backgrounds (Fig. 5
D–F and SI Appendix, Fig. S3).
We next tested the ΔcycA and ΔsstT mutants for transcrip-
tional response to D-Ser using a dual LEE1-gfp and recA-rfp re-
porter system. Similar to LCV4 to 10 and 1A, mutants lacking
cycA no longer showed repression of LEE1 (Fig. 5G) or activa-
tion of recA (Fig. 5H) after 4 h of growth. A 4.97-fold higher level
of recA expression was seen with WTD-Ser versus WT (P = 0.003)
at 5 h, while D-Ser caused only a 1.07-fold induction of recA (P =
0.006) in the ΔcycA background. Transport of D-Ser via CycA
appeared to be the predominant factor in determining tran-
scriptional response as deletion of sstT provided no relief from
D-Ser–induced type 3 repression (SI Appendix, Fig. S4A) or recA
activation (SI Appendix, Fig. S4B). As seen with the corresponding
LCV isolate (LCV10; Fig. 3 C–E), recovery from repression of
LEE1 (Fig. 5G) by disruption of D-Ser transport correlated with
increased efficiency of colonization in a HeLa cell infection model
(Fig. 5 I–K). Unlike WT EHEC, D-Ser no longer caused a re-
duction in visible A/E lesions (Fig. 5I), bacteria per cell (Fig. 5J),
or percentage of cells infected (Fig. 5K). The data obtained from
these isogenic transporter deletion mutants corroborate the results
obtained with LCV4 to 10 and 1A and further support the idea
that disruption of CycA and SstT can result in tolerance to D-Ser
with implications for stress response and virulence of EHEC.
A Transport-Independent Mechanism of Tolerance? The data pre-
sented thus far suggest that disruption to serine transport systems
Table 1. Mutations detected in D-serine–adapted EHEC isolates
Gene/region mutated Mutation Alteration in amino acid sequence† Annotation Isolate(s) possessing mutation
cycA MNP I257K Transporter 1A
tamB SNP S358R Membrane assembly 1A
ygfL SNP I384V Enzyme 3
cycA SNP K280* Transporter 4 to 10
z1097 INS NNK411NNNK*I Hypothetical 9
z2148 SNP R52G Phage tail 10 and 10B
z1364 SNP None Phage portal 1 and 2
z1364 SNP None Phage portal 2
yqhD SNP None Enzyme 3
z2148 SNP None Phage tail 10B
z2148 SNP None Phage tail 10B
INS, insertion; MNP, multiple-nucleotide polymorphism.
†Stop codon (*).
Fig. 4. Constitutive knockdown in the serine transporter SstT occurs in isolates that possess a premature stop codon in cycA and display complete D-Ser
tolerance. (A) Representative RNA-sequencing (RNA-seq) tracks of WT and LCV10 cultured for 5 h in MEM-HEPES + 1 mM D-Ser together with a schematic
illustrating the gene organization within this locus. (B and C) Quantitative real-time PCR of sstT transcription following 5 h of growth in M9 + Glc ± 1 mM
D-Ser. Triplicate experimental values for each isolate were compared with the WT with *P < 0.05, **P < 0.01, and ***P < 0.001 by unpaired two-tailed
Student’s t test. ns, not significant.
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can contribute to D-Ser tolerance; however, two tolerant isolates
remained for which no transport-related SNPs were identified
(LCV2 and LCV10B; Table 1). To investigate the underlying tol-
erance mechanism, we employed transcriptome profiling. Com-
paring WTD-Ser and LCV2D-Ser revealed 660 DEGs, 258 of which
comprised genes differentially expressed upon WT treatment with
D-Ser (SI Appendix, Table S3). Of these, 233 were oppositely reg-
ulated, illustrating that, similar to LCV10, LCV2 had overcome the
majority of transcriptional alterations exerted on WT EHEC by
D-Ser. Comparing WTD-Ser and LCV2D-Ser also revealed 401 new
DEGs not included in the WT/WTD-Ser comparison, indicating that
the transcriptional alterations in LCV2 extended beyond simply
Fig. 5. Deletion of serine transporters CycA and SstT reproduces phenotypes of tolerant isolates. (A–F) Growth curves of the WT, cycA, sstT, and cycA/sstT double
mutant, and corresponding complementation strains in M9 + Glc ± 1 mM D-Ser. Error bars indicate SEM with a minimum of three experiments being performed.
(G and H) Dual LEE1-gfp/recA-rfp promoter fusion reporter analysis of the WT and cycA mutants cultured in MEM-HEPES at the indicated time points. Three
experiments were performed, with error bars depicting SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 by paired two-tailed Student’s t test. (I–K) Colonization of
HeLa cells as determined by counting the numbers of EHEC attached per cell after 2 h 45m of infection. (I) Deconvoluted wide-field microscopy images illustrating
DNA (blue), filamentous actin (red), and EHEC (green) with bacteria being associated with regions of condensed actin. (J) Individual counts of bacteria per HeLa
cell. A minimum of 350 cells were counted across three experiments. Black lines indicate the mean. Kruskal–Wallis with Dunn’s post hoc test yielded ***P < 0.001.
(K) Percentage of HeLa infected with at least one EHEC cell. Ordinary one-way ANOVA of experimental means yielded ***P < 0.001.
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overcoming the effects of D-Ser. Among the most significant
of these alterations were decreased expression of cscR/z3626
(−147.74-fold, P = 6.50 × 10−39) and up-regulation of cscA/z3625
(58.29-fold, P = 2.66 × 10−122), cscK/z3624 (155.74-fold, P = 2.89 ×
10−89), cscB/z3623 (28.24-fold, P = 2.58 × 10−67), and dsdA (33.05-
fold, P = 1.34 × 10−108).
The first of these genes (cscR) was particularly interesting as
no reads were obtained for LCV2D-Ser (Fig. 6A), accounting for
the apparent large degree of differential expression. We hypoth-
esized that a large genomic rearrangement may have occurred
within this region that was not detected by our SNP-calling pipe-
line. Manual assessment of genome sequencing from this region in
LCV2 and LCV10B showed a striking lack of coverage, suggesting
that genomic reorganization had led to a loss of genomic content
(SI Appendix, Fig. S5A). Primers flanking the putative deletion site
of LCV10B (annealing sites indicated by red lines in Fig. 6A) were
used to screen all LCVs for similar deletions. Only LCV2 and
LCV10B were found to have truncations in this region (SI Ap-
pendix, Fig. S5B). Sanger sequencing of the PCR amplicons from
LCV2 and LCV10B confirmed the precise coordinates of the
deletions. LCV2 possessed a 1,120-bp deletion spanning from
149 bp before the 3′ end of cscA to 8 bp downstream of the 5′ end
of cscR (Fig. 6A) with a 2-bp direct repeat of CG flanking the
deletion site (red dashed boxes in Fig. 6A). LCV10B possessed a
5,637-bp deletion spanning from 32 bp before the 3′ end of z3622
to 122 bp downstream of the 5′ end of cscR (Fig. 6A) with an 8-bp
direct repeat of CCGGATAA flanking the deletion site (blue
dashed boxes in Fig. 6A). CscR represses the transcription of the
sucrose utilization locus encoded by cscBKA (17). As the deletions
in LCV2 and LCV10B resulted in loss of the 3′ end of cscA and
the entire csc locus, respectively, these isolates lost their ability to
grow on sucrose as a sole carbon source (SI Appendix, Fig. S5C).
As mentioned previously, loss of transcription of cscR in LCV2
coincided with increased transcription of not only cscBKA via dere-
pression but also increased transcription of the D-Ser deaminase-
encoding gene dsdA (Fig. 6A and SI Appendix, Table S3). This
indicated that LCV2 and LCV10B may have gained an ability to
catabolize D-Ser. Both LCV2D-Ser and LCV10BD-Ser exhibited enhanced
growth (SGR, 0.53 and 0.53 h−1) compared with culture in minimal
essential media-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(MEM-HEPES) without D-Ser (0.40 and 0.41 h−1), whereas WT
EHEC (0.41 h−1) displayed reduced growth upon inclusion of D-Ser
(0.37 h−1; Fig. 6 B and C and SI Appendix, Fig. S6A). Both
LCV2D-Ser and LCV10BD-Ser also reached a higher maximal OD600 nm
than WTD-Ser, while no difference was observed when D-Ser was
absent (Fig. 6 B and C and SI Appendix, Fig. S6B), indicating that
D-Ser contributed to increased biomass accumulation in LCV2 and
10B. Quantitation of D-Ser concentrations in this medium con-
firmed that enhanced growth of these strains correlated with the
consumption of D-Ser with significantly lower levels of D-Ser being
present in cell-free supernatants from LCV2 and LCV10B at 4, 5,
and 6 h compared with WT EHEC (Fig. 6D). An isogenic cscR
deletion mutant recapitulated the tolerance phenotype of LCV2
and LCV10B in M9 medium (Fig. 6E) and this phenotype was
successfully complemented by reintroduction of cscR in trans
(Fig. 6F and SI Appendix, Fig. S7). The ΔcscR mutant also displayed
enhanced growth rate and maximal OD600 nm in MEM-HEPES +
D-Ser in support of catabolism and assimilation into biomass (Fig. 6G).
Reactivation of dsdA via Tolerance-Mediated Adaptive Mutation.
There were two plausible explanations for the activation of the
previously nonfunctional D-Ser deaminase gene dsdA by upstream
genomic deletions. One possibility was that deletion of the tran-
scriptional repressor CscR led to direct derepression of dsdA
transcription via its own promoter, dsdAp. The second explanation
was that the alteration in genomic context of dsdA could lead to
control via read-through from alternative promoters such as cscAp
in the case of LCV2 or z3622p in the case of LCV10B.
To explore the first possibility, we examined the effect of
heterologous CscR expression in UPEC. UPEC lacks the csc
sucrose utilization locus and, as previously mentioned, possesses
a functional dsd system for catabolism of D-Ser. The promoter
element of dsdA is located 115 bp upstream of the start codon;
114 bp of this sequence are conserved between EHEC and
UPEC and, as such, it could be expected that any putative CscR
binding in this region would also be conserved. Expression of
CscR in UPEC did not result in a decrease in tolerance to D-Ser
in M9 minimal medium (SI Appendix, Fig. S8A), as carriage of
empty pACYC184 and pcscR resulted in similar rates of growth.
Qualitative real-time PCR demonstrated that transcription of
UPEC dsdCXA occurred at a low steady-state level but increased
markedly within 5 min postaddition of D-Ser and remained at a
steady state for at least 20 min (SI Appendix, Fig. S8B). Real-
time PCR at 0, 10, and 20 min and quantitative real-time PCR at
0 and 20 min revealed that expression of CscR did not reduce the
steady-state level of dsdCXA transcription and did not affect the
ability of dsdCXA to respond to D-Ser (SI Appendix, Fig.
S8 B–E). It therefore appeared that CscR was not a direct re-
pressor of D-Ser catabolism.
The activation of dsdA by a new upstream regulatory element
seemed more plausible given the data presented in Fig. 6A. The
transcript read density for dsdA appears to correlate well with
that of cscA, supporting the assertion that dsdA transcription in
this strain may be driven by cscAp. The deletion in LCV2 was
particularly serendipitous as it not only allowed for control via
increasing the proximity of cscAp to dsdA but also via dere-
pression of cscAp due to loss of CscR. To further test how the
genomic organization of these regions affected dsdA expression,
the relevant chromosomal regions (from cscAp or z3622p to the
sixth codon of dsdA) of WT, LCV2, or LCV10B were fused to gfp
(Fig. 7A) in a reporter plasmid such that green fluorescent
protein (GFP) production could be used as a proxy for DsdA
expression. As expected, the fragments that comprised gfp under
the control of the canonical DsdA control elements (Fig. 7,
fragments i and iii) produced low levels of fluorescence (63 to
134 relative fluorescence units; RFUs) and behaved similarly.
Fragments ii and iv that were amplified from LCV2 and 10B and
comprised gfp that was predicted to be under the control of
cscAp and z3622p, respectively, produced fluorescence signifi-
cantly higher (2,001 and 257 RFUs) than that of the WT am-
plified fragments, reflecting the constitutive activation of DsdA
in these genetic contexts. Of particular interest was the fact that
GFP production from fragment ii was significantly higher in the
ΔcscR mutant than the WT whereas no significant difference
between WT and mutant was observed with fragment iv. This
illustrates that DsdA expression in LCV2 is further facilitated by
derepression of cscAp due to lack of CscR, whereas expression
via z3622p in LCV10B is not affected by CscR. This also explains
why complementation of the ΔcscR mutant tolerance phenotype
(Fig. 6F) is possible despite the fact that the change in chromosomal
context is the principal driver of DsdA activity (i.e., overexpression
of cscR in trans is capable of repressing dsdA in the ΔcscR mutant
through interaction with chromosomal cscAp).
Discussion
There is a growing appreciation for the role that the metabolic
state of the gut plays in determining the behavior of both path-
ogenic and commensal bacteria. In particular, diet plays a vital
role in determining health and disease outcomes, not only through
manipulation of the nutritional balance of the host but also through
modulation of bacterial species composition and gene expression
(26, 27). It has been recently demonstrated that the use of trehalose
as a food additive has led to the evolution of new lineages of
Clostridium difficile with enhanced virulence and metabolic capacity
(28), highlighting the importance of understanding how bacterial
adaptation to dietary components can influence disease outcomes.
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Many studies have pointed toward important roles for distinct
dietary constituents in manipulating virulence and the progres-
sion of disease by A/E pathogens. Dietary fiber has been directly
implicated in affecting disease severity in EHEC (29), while
supplementation of diet with phytonutrients (plant extracts) (30)
and pectin (31) reduce the severity of infection by Citrobacter
rodentium—a natural pathogen of mice that employs a LEE-
encoded type 3 secretion system similar to EHEC for intestinal
colonization. Fucose has also been shown to repress expression
of the LEE in EHEC via the fucose two-component sensor
FusKR (32); however, the main source of free fucose is thought
to be cleavage of intestinal mucins by commensal bacteria, while
the contribution of diet to free fucose levels in the gut has been
poorly studied (33). Similarly, biotin was shown to repress the
LEE via the biotin sensor BirA which represses transcription of
the global transcriptional regulator Fur, preventing it from ac-
tivating the LEE (34). Accordingly, mice fed a high-biotin diet
showed lower levels of intestinal colonization.
Of particular relevance to this study, catabolism of L-serine was
recently shown to confer a competitive advantage to adherent
invasive E. coli (AIEC) under chemically induced murine colitis
and also to C. rodentium that can naturally induce colitis in mice
(35). Pathogenic AIEC were better able to outcompete the non-
pathogenic strain MG1655 when germfree mice were provided
Fig. 6. Genomic rearrangements upstream of the inactive EHEC dsd locus result in activation of D-Ser catabolism, thereby allowing tolerance via a distinct
mechanism. (A) Representative RNA-seq tracks of the WT and LCV2 cultured in MEM-HEPES D-Ser for 5 h. Gene tracks indicate WT, LCV2, and LCV10B organi-
zation. Red/blue dashed boxes indicate direct repeats identified flanking the deletion in LCV2/10B, respectively. Annealing sites for primers used to screen for
deletions in this region are indicated by red lines above and below each gene track. (B and C) Growth curves of LCV2 and LCV10B cultured in MEM-HEPES ± 1 mM
D-Ser. Error bars indicate SEM with a minimum of three experiments being performed. (D) Concentration of D-Ser in cell-free supernatant from MEM-HEPES
cultures as determined by D-Ser assay. The experiment was performed in triplicate. Error bars indicate SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 by unpaired
two-tailed Student’s t test. (E and F) Growth curves of the WT, ΔcscR (E), and cscR complementation strains (F) cultured in M9 + Glc ± 1 mM D-Ser. (G) Growth
curves of the WT and ΔcscR cultured in MEM-HEPES ± 1 mM D-Ser. Error bars indicate SEM with a minimum of three experiments being performed (E–G).
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with a diet containing L-serine compared with a serine-deficient
diet. Although L-serine does not influence expression of type 3
secretion genes in EHEC (10), this study raises the possibility that
catabolism of both D- and L-serine may provide a competitive
advantage to pathogenic E. coli during infection. Adaptation to
D-Ser in this study resulted in two clones (LCV2 and LCV10B)
gaining the ability to catabolize D-Ser, thereby not only alleviating
toxicity as observed by overcoming growth inhibition and SOS
induction but also expanding the available carbon and nitrogen
source repertoire of the organism. The resulting enhanced growth
rate of these isolates in D-Ser (Fig. 6 B and C) contributes to the
higher numbers of colonizing bacteria observed with LCV2D-Ser
compared with WTD-Ser (Fig. 3D) despite LEE repression being
retained (Fig. 3A). In an in vivo context, this could potentially
increase metabolic fitness in otherwise unfavorable environments.
The identification of genetically distinct mutants after 10 suc-
cessive batch cultures is not surprising and is likely reflective of the
fact that there are multiple routes to tolerance. Laboratory-based
evolution experiments have been reported to result in convergent
growth phenotypes via distinct modifications in gene expression
states (36). Enteric species often partake in diverse adaptive
strategies with genotypic and phenotypic heterogeneity allowing
for enhanced versatility in the face of stress and competition (37,
38). In the complex and dynamic environment of the gut, muta-
tions may be advantageous or deleterious depending on specific
conditions. As such, heterogeneity represents a savvy route to
establishment or maintenance of a successful niche. It is possible
that there are further diverse mechanisms by which D-Ser toler-
ance can arise, each with varying implications for the expression of
virulence and metabolism genes. Deep sequencing of a long-term
adapted batch culture would yield interesting insight into potential
heterogeneity of adaptation within a given population.
While the complete tolerance of LCV8 to 10 can be explained
by reduced expression of SstT in conjunction with expression of a
mutated CycA, the reason for this reduced rate of transcription is
unclear. There appears to be an accumulation of antisense reads
in the 5′ untranslated region of sstT, so it is tempting to speculate
that control via a regulatory RNA may be at play. Both sstT (39)
and cycA (40) have been shown to be regulated by the small RNA
GcvB; however, no change in gcvB transcription was observed, nor
were mutations in the GcvB binding site of sstT in LCV8 to 10
detected (Table 1). It should be noted that WT EHEC responds to
D-Ser by reducing transcription of cycA (−2.38-fold, P = 4.09 ×
10−4). As such, EHEC may respond to D-Ser by decreasing the
transcription of D-Ser transporters; however, the precise regulatory
framework through which constitutive knockdown of sstT is achieved
remains elusive.
The mechanism by which D-Ser exerts its toxic growth-inhibitory
effect on catabolically inactive E. coli has been the subject of some
debate. Using a mutant of E. coli K-12 unable to produce D-Ser
deaminase, it was shown that addition of L-serine and pantothenate
could rescue the tolerance phenotype, thereby implicating a block in
L-serine biosynthesis or pantothenate synthesis in D-Ser–induced
toxicity (41). This may also explain why D-Ser does not induce
growth arrest in more complex media such as MEM-HEPES
(Fig. 5B). D-amino acids can be misincorporated into the peptido-
glycan of gram-negative bacteria in place of the canonical cell-wall
constituent D-amino acids (9, 42). We have previously speculated
that the mechanism of D-Ser toxicity may involve a disruption to the
peptidoglycan-remodeling machinery that is essential for growth,
due to a modified composition of the muropeptide chains (10). The
results of this study indicate that regardless of the mechanism of
toxicity, disruption of D-Ser transport into the cytosol is sufficient to
abrogate the inhibition of growth. Analysis of 115 E. coli O157:H7
genomes (National Center for Biotechnology Information BLASTp)
reveals strict conservation (>99%) at the amino acid level for CycA
and SstT, indicating strong selective pressure. CycA and SstT possess
multiple amino acid substrates including alanine, threonine, and
glycine. Disruption of transport of these molecules may compro-
mise fitness in certain environments by reducing the efficacy of
transport and catabolism of specific carbon and nitrogen sources.
The deletions observed upstream of dsdA in this study result in a
similar evolutionary tradeoff with such mutants losing the ability
to metabolize sucrose. It will be important to analyze the effect of
such alterations in the context of an in vivo infection.
Laboratory-based evolution studies have yielded valuable in-
sight into how E. coli adapts to stress (43–45) and can acquire the
ability to derive nutrition from noncanonical carbon sources (46,
47). In this study, we have described how multiple genetic mecha-
nisms converge in surmounting D-Ser–induced stress in EHEC with
each mechanism having implications for important pleiotropic
behaviors including virulence, stress response, and catabolic capacity.
We previously showed that the sensing of D-Ser and concordant
repression of type 3 secretion-dependent colonization restrict EHEC
to the gut (10). The present study aimed to investigate how EHEC
might overcome this evolutionary bottleneck. The growth inhi-
bition associated with D-Ser is not linked to type 3 repression as
shown by our previous work. The data presented here indicate
that through genomic plasticity, EHEC can overcome both the
repression of colonization and growth-inhibitory effects of D-Ser.
Hence, these adaptations could expand the niche specificity of
EHEC, enabling infection in extraintestinal sites such as the
bladder, thereby challenging the dogma that EHEC are strictly
intestinal pathogens (10, 15). Caution should be exercised with
Fig. 7. Deletions upstream of dsd enhance dsdA transcription due to control via alternative promoters. (A) Schematic representation of the genetic fusions
prepared from the WT, LCV2, and LCV10B to examine the effect of altered genomic context on expression of dsdA. (B) Reporter assay carried out using gfp
fusion constructs (i–iv, A). Gene regions were amplified from the indicated strains, cloned upstream of gfp, and transformed into the WT and ΔcscR. Fluo-
rescence was recorded after a 4-h culture in MEM-HEPES with GFP production serving as a proxy for dsdA transcription. Triplicate experiments were per-
formed. Error bars indicate SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 by paired two-tailed Student’s t test.
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this assertion as such mutations have yet to appear in the data-
base. This could indicate that environmental substrate sampling
via CycA acts as a critical regulator of niche restriction and loss
of functionality could lead to a compromise in pathogen success.
However, there have been recent reports of EHEC/UPEC hybrid
strains (48, 49) with the ability to cause both intestinal and extra-
intestinal disease, suggesting that adaptation to alternative niches
may already be occurring. Understanding the in vivo ecological
implications of the adaptive mechanisms described here will
form the basis of our future work.
Materials and Methods
A complete list of bacterial strains, plasmids, and oligonucleotides used in this
study can be found in SI Appendix, Tables S4–S6. A detailed description of all
methodology is included in SI Appendix, Materials and Methods. This in-
cludes isolation of D-Ser–tolerant mutants, engineering of strains and plasmids,
HeLa cell infections, DNA and RNA extraction, library preparation and sequenc-
ing, quantitative real-time PCR, D-Ser assay, and all data analysis tools.
Data Availability. Raw sequence data reported in this paper have been de-
posited in the European Nucleotide Archive under accession nos. ERS4281497
to ERS4281509 (genome sequencing) and ERS4281510 to ERS4281521 (RNA
sequencing). All remaining data are presented in the paper and SI Appendix.
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